• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆抑制前列腺癌 PC3 细胞迁移,并在体外抑制破骨细胞分化。

Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.

机构信息

Peking University School of Pharmaceutical Sciences, 38 Xueyuan Road, Beijing 100191, Peoples Republic of China.

出版信息

Cell Biol Int. 2011 Nov;35(11):1159-67. doi: 10.1042/CBI20100870.

DOI:10.1042/CBI20100870
PMID:21605080
Abstract

This study examined whether Gd (gadolinium) could suppress prostate cancer cell migration and prostate cancer cell-induced osteoclast differentiation. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] and colony forming assay showed that GdCl3 treatment inhibited both cell viability and colony forming ability in PC3 cells more significantly than that in DU145 cells. Annexin/PI (propidium iodide) staining showed an increase in apoptotic death of PC3 cells in the presence of GdCl3. Wound healing and adhesion assay indicated that GdCl3 suppressed PC3 cell migration. Western-blot analysis demonstrated that GdCl3 treatment inhibited phosphorylation of ERK (extracellular-signal-regulated kinase) and p38 MAPK (mitogen-activated protein kinase). Pretreatment with PTx (pertussis toxin), a Gi protein inhibitor, conferred resistance to GdCl3-induced colony formation, ERK and p38 phosphorylation in PC3 cells. Moreover, GdCl3 inhibited PC3 cell-induced osteoclast differentiation. RT-PCR (reverse transcription-PCR) indicated that GdCl3 decreased the expression of RANKL (receptor activator of nuclear factor-κB ligand) in PC3 cells, whereas it increased the expression of OPG (osteoprotegerin) in PC3 and DU145 cells. In conclusion, the present study indicated that GdCl3 inhibited PC3 cell migration mediated by the inactivation of both ERK and p38 MAPK pathways via PTx-sensitive G proteins, and also suppressed PC3 cell-induced osteoclast differentiation via regulating the mRNA expression of OPG and RANKL.

摘要

本研究旨在探讨钆(Gd)能否抑制前列腺癌细胞迁移和前列腺癌细胞诱导的破骨细胞分化。MTT [3-(4,5-二甲基噻唑-2-基)-2,5-二苯基-2H-四唑溴盐]和集落形成实验表明,GdCl3 处理对 PC3 细胞的细胞活力和集落形成能力的抑制作用明显强于 DU145 细胞。Annexin/PI(碘化丙啶)染色显示 GdCl3 存在时 PC3 细胞凋亡死亡增加。划痕愈合和黏附实验表明 GdCl3 抑制 PC3 细胞迁移。Western-blot 分析表明 GdCl3 抑制 ERK(细胞外信号调节激酶)和 p38 MAPK(丝裂原激活蛋白激酶)的磷酸化。Gi 蛋白抑制剂百日咳毒素(PTx)预处理赋予 PC3 细胞对 GdCl3 诱导的集落形成、ERK 和 p38 磷酸化的抗性。此外,GdCl3 抑制 PC3 细胞诱导的破骨细胞分化。RT-PCR(逆转录-PCR)表明 GdCl3 降低了 PC3 细胞中 RANKL(核因子-κB 配体受体激活剂)的表达,而增加了 PC3 和 DU145 细胞中 OPG(骨保护素)的表达。综上所述,本研究表明 GdCl3 通过 PTx 敏感的 Gi 蛋白抑制 PC3 细胞迁移,通过调节 OPG 和 RANKL 的 mRNA 表达抑制 PC3 细胞诱导的破骨细胞分化。

相似文献

1
Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.钆抑制前列腺癌 PC3 细胞迁移,并在体外抑制破骨细胞分化。
Cell Biol Int. 2011 Nov;35(11):1159-67. doi: 10.1042/CBI20100870.
2
Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.骨保护素通过钙、细胞外信号调节激酶(ERK)和p38丝裂原活化蛋白激酶(MAPK)信号通路诱导破骨细胞中足体解体。
Cytokine. 2015 Feb;71(2):199-206. doi: 10.1016/j.cyto.2014.10.007. Epub 2014 Nov 20.
3
DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.DU145人前列腺癌细胞表达核因子κB受体激活剂:前列腺癌骨转移过程中的新见解。
Bone. 2007 Apr;40(4):981-90. doi: 10.1016/j.bone.2006.11.006. Epub 2006 Dec 28.
4
CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.CTRP3在体外通过AMPK-c-Fos-NFATc1信号传导充当破骨细胞生成的负调节因子,并在体内抑制RANKL诱导的颅骨骨破坏。
Bone. 2015 Oct;79:242-51. doi: 10.1016/j.bone.2015.06.011. Epub 2015 Jun 21.
5
RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.核因子κB受体活化因子配体(RANKL)直接作用于表达核因子κB受体活化因子(RANK)的前列腺肿瘤细胞,并介导肿瘤转移基因的迁移和表达。
Prostate. 2008 Jan 1;68(1):92-104. doi: 10.1002/pros.20678.
6
Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.蜥内酰胺抑制破骨细胞分化并刺激成熟破骨细胞凋亡。
J Cell Physiol. 2009 Dec;221(3):618-28. doi: 10.1002/jcp.21892.
7
Cannabinoid receptor-2 selective antagonist negatively regulates receptor activator of nuclear factor kappa B ligand mediated osteoclastogenesis.大麻素受体-2 选择性拮抗剂负调控核因子-κB 配体受体激活剂介导的破骨细胞生成。
Chin Med J (Engl). 2011 Feb;124(4):586-90.
8
Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.HepaCAM 的过表达通过抑制雄激素受体和 ERK 信号转导在前列腺癌细胞中的核易位抑制细胞活力和迁移。
Prostate. 2014 Jul;74(10):1023-33. doi: 10.1002/pros.22817. Epub 2014 May 8.
9
The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.靶向MET/血管内皮生长因子受体(VEGFR)的酪氨酸激酶抑制剂也可减弱前列腺癌诱导的FMS依赖的破骨细胞分化和骨破坏。
J Biol Chem. 2016 Sep 30;291(40):20891-20899. doi: 10.1074/jbc.M116.727875. Epub 2016 Aug 18.
10
Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.辛伐他汀通过调节丝裂原活化蛋白激酶(MAPK)、蛋白激酶B(AKT)和Src信号通路,抑制骨形态发生蛋白-2(BMP-2)和核因子κB受体活化因子配体(RANKL)诱导的破骨细胞分化。
Regul Pept. 2010 Jun 8;162(1-3):99-108. doi: 10.1016/j.regpep.2010.03.003. Epub 2010 Mar 24.

引用本文的文献

1
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents-A Review.钆及基于钆的造影剂的毒性机制——综述。
Int J Mol Sci. 2024 Apr 6;25(7):4071. doi: 10.3390/ijms25074071.
2
Understanding and targeting osteoclastic activity in prostate cancer bone metastases.了解并靶向治疗前列腺癌骨转移中的破骨细胞活性。
Curr Mol Med. 2013 May;13(4):626-39. doi: 10.2174/1566524011313040012.